BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8822272)

  • 1. High frequency deletion of the tumour suppressor gene P16INK4a (MTS1) in human thyroid cancer cell lines.
    Jones CJ; Shaw JJ; Wyllie FS; Gaillard N; Schlumberger M; Wynford-Thomas D
    Mol Cell Endocrinol; 1996 Jan; 116(1):115-9. PubMed ID: 8822272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
    Sonoda Y; Yoshimoto T; Sekiya T
    Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infrequent CDKN2 mutation in human differentiated thyroid cancers.
    Tung WS; Shevlin DW; Bartsch D; Norton JA; Wells SA; Goodfellow PJ
    Mol Carcinog; 1996 Jan; 15(1):5-10. PubMed ID: 8561866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of p16/CDKN2 alterations in thyroid carcinomas.
    Yane K; Konishi N; Kitahori Y; Naito H; Okaichi K; Ohnishi T; Miyahara H; Matsunaga T; Hiasa Y
    Cancer Lett; 1996 Mar; 101(1):85-92. PubMed ID: 8625287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
    Moulton T; Samara G; Chung WY; Yuan L; Desai R; Sisti M; Bruce J; Tycko B
    Am J Pathol; 1995 Mar; 146(3):613-9. PubMed ID: 7887443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
    Geradts J; Kratzke RA; Niehans GA; Lincoln CE
    Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.
    Shapiro GI; Park JE; Edwards CD; Mao L; Merlo A; Sidransky D; Ewen ME; Rollins BJ
    Cancer Res; 1995 Dec; 55(24):6200-9. PubMed ID: 8521414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare loss of heterozygosity of the MTS1 and MTS2 tumor suppressor genes in differentiated human thyroid cancer.
    Schulte KM; Staudt S; Niederacher D; Finken-Eigen M; Köhrer K; Goretzki PE; Röher HD
    Horm Metab Res; 1998 Sep; 30(9):549-54. PubMed ID: 9808321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multiple tumor suppressor 1/cyclin-dependent kinase inhibitor 2 gene in human central nervous system primitive neuroectodermal tumor.
    Raffel C; Ueki K; Harsh GR; Louis DN
    Neurosurgery; 1995 May; 36(5):971-4; discussion 974-5. PubMed ID: 7791990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cell cycle regulator potentially involved in genesis of many tumor types.
    Kamb A; Gruis NA; Weaver-Feldhaus J; Liu Q; Harshman K; Tavtigian SV; Stockert E; Day RS; Johnson BE; Skolnick MH
    Science; 1994 Apr; 264(5157):436-40. PubMed ID: 8153634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan.
    Lin YW; Chen CH; Huang GT; Lee PH; Wang JT; Chen DS; Lu FJ; Sheu JC
    Eur J Cancer; 1998 Oct; 34(11):1789-95. PubMed ID: 9893670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines.
    Southgate J; Proffitt J; Roberts P; Smith B; Selby P
    Br J Cancer; 1995 Nov; 72(5):1214-8. PubMed ID: 7577470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4A/MTS1) gene structure and expression in acute lymphoblastic leukemias.
    Delmer A; Tang R; Senamaud-Beaufort C; Paterlini P; Brechot C; Zittoun R
    Leukemia; 1995 Jul; 9(7):1240-5. PubMed ID: 7630199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
    Shi Y; Zou M; Farid NR; al-Sedairy ST
    Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines.
    Aagaard L; Lukas J; Bartkova J; Kjerulff AA; Strauss M; Bartek J
    Int J Cancer; 1995 Mar; 61(1):115-20. PubMed ID: 7705923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16ink4a gene and hematological malignancies.
    Quesnel B; Preudhomme C; Fenaux P
    Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.
    Huang L; Goodrow TL; Zhang SY; Klein-Szanto AJ; Chang H; Ruggeri BA
    Cancer Res; 1996 Mar; 56(5):1137-41. PubMed ID: 8640773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death.
    Weng LP; Gimm O; Kum JB; Smith WM; Zhou XP; Wynford-Thomas D; Leone G; Eng C
    Hum Mol Genet; 2001 Feb; 10(3):251-8. PubMed ID: 11159944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
    Lukas J; Parry D; Aagaard L; Mann DJ; Bartkova J; Strauss M; Peters G; Bartek J
    Nature; 1995 Jun; 375(6531):503-6. PubMed ID: 7777060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.